• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

错误患者记录对群体药代动力学建模和个体贝叶斯估计的影响。

Influence of erroneous patient records on population pharmacokinetic modeling and individual bayesian estimation.

机构信息

Department of Anesthesiology, Maastricht University Medical Centre, Maastricht, the Netherlands.

出版信息

Ther Drug Monit. 2012 Oct;34(5):526-34. doi: 10.1097/FTD.0b013e3182616937.

DOI:10.1097/FTD.0b013e3182616937
PMID:22846895
Abstract

BACKGROUND

Observational data sets can be used for population pharmacokinetic (PK) modeling. However, these data sets are generally less precisely recorded than experimental data sets. This article aims to investigate the influence of erroneous records on population PK modeling and individual maximum a posteriori Bayesian (MAPB) estimation.

METHODS

A total of 1123 patient records of neonates who were administered vancomycin were used for population PK modeling by iterative 2-stage Bayesian (ITSB) analysis. Cut-off values for weighted residuals were tested for exclusion of records from the analysis. A simulation study was performed to assess the influence of erroneous records on population modeling and individual MAPB estimation. Also the cut-off values for weighted residuals were tested in the simulation study.

RESULTS

Errors in registration have limited the influence on outcomes of population PK modeling but can have detrimental effects on individual MAPB estimation. A population PK model created from a data set with many registration errors has little influence on subsequent MAPB estimates for precisely recorded data. A weighted residual value of 2 for concentration measurements has good discriminative power for identification of erroneous records.

CONCLUSIONS

ITSB analysis and its individual estimates are hardly affected by most registration errors. Large registration errors can be detected by weighted residuals of concentration.

摘要

背景

观察性数据集可用于群体药代动力学(PK)建模。然而,这些数据集通常比实验数据集记录得不够准确。本文旨在研究错误记录对群体 PK 建模和个体最大后验贝叶斯(MAPB)估计的影响。

方法

采用迭代 2 阶段贝叶斯(ITSB)分析,对接受万古霉素治疗的新生儿的 1123 例患者记录进行群体 PK 建模。测试了加权残差的截止值,以排除分析中的记录。进行了一项模拟研究,以评估错误记录对群体建模和个体 MAPB 估计的影响。还在模拟研究中测试了加权残差的截止值。

结果

注册错误对群体 PK 建模结果的影响有限,但对个体 MAPB 估计有不利影响。从存在大量注册错误的数据集中创建的群体 PK 模型对精确记录的数据的后续 MAPB 估计几乎没有影响。浓度测量的加权残差为 2 具有良好的辨别力,可用于识别错误记录。

结论

ITSB 分析及其个体估计受大多数注册错误的影响较小。浓度的加权残差可检测到较大的注册错误。

相似文献

1
Influence of erroneous patient records on population pharmacokinetic modeling and individual bayesian estimation.错误患者记录对群体药代动力学建模和个体贝叶斯估计的影响。
Ther Drug Monit. 2012 Oct;34(5):526-34. doi: 10.1097/FTD.0b013e3182616937.
2
Population pharmacokinetic modeling and optimal sampling strategy for Bayesian estimation of amikacin exposure in critically ill septic patients.群体药代动力学模型和最佳采样策略在重症脓毒症患者中贝叶斯估算阿米卡星暴露的应用。
Ther Drug Monit. 2010 Dec;32(6):749-56. doi: 10.1097/FTD.0b013e3181f675c2.
3
Simultaneous versus sequential pharmacokinetic-pharmacodynamic population analysis using an iterative two-stage Bayesian technique.使用迭代两阶段贝叶斯技术进行同步与序贯药代动力学-药效学群体分析。
Biopharm Drug Dispos. 2007 Nov;28(8):455-73. doi: 10.1002/bdd.575.
4
DosOpt: A Tool for Personalized Bayesian Dose Adjustment of Vancomycin in Neonates.DosOpt:一种用于新生儿万古霉素个性化贝叶斯剂量调整的工具。
Ther Drug Monit. 2017 Dec;39(6):604-613. doi: 10.1097/FTD.0000000000000456.
5
Optimal sampling strategy development methodology using maximum a posteriori Bayesian estimation.基于最大后验贝叶斯估计的最优采样策略开发方法。
Ther Drug Monit. 2011 Apr;33(2):133-46. doi: 10.1097/FTD.0b013e31820f40f8.
6
A hybrid machine learning/pharmacokinetic approach outperforms maximum a posteriori Bayesian estimation by selectively flattening model priors.混合机器学习/药代动力学方法通过选择性地使模型先验平坦化,从而优于最大后验贝叶斯估计。
CPT Pharmacometrics Syst Pharmacol. 2021 Oct;10(10):1150-1160. doi: 10.1002/psp4.12684. Epub 2021 Jul 26.
7
Performance of an iterative two-stage bayesian technique for population pharmacokinetic analysis of rich data sets.用于丰富数据集群体药代动力学分析的迭代两阶段贝叶斯技术的性能
Pharm Res. 2006 Dec;23(12):2748-59. doi: 10.1007/s11095-006-9116-0. Epub 2006 Nov 7.
8
Evaluations of Bayesian and maximum likelihood methods in PK models with below-quantification-limit data.贝叶斯方法和最大似然法在具有低于定量限数据的药代动力学模型中的评估。
Pharm Stat. 2010 Oct-Dec;9(4):313-30. doi: 10.1002/pst.400.
9
Pharmacokinetic modelling and Bayesian estimation-assisted decision tools to optimize vancomycin dosage in neonates: only one piece of the puzzle.药代动力学建模和贝叶斯估计辅助决策工具优化新生儿万古霉素剂量:只是拼图的一部分。
Expert Opin Drug Metab Toxicol. 2019 Sep;15(9):735-749. doi: 10.1080/17425255.2019.1655540. Epub 2019 Aug 19.
10
[Can we use a Bayesian method to build a pharmacokinetic population in two steps?].我们能否分两步使用贝叶斯方法构建药代动力学群体?
Therapie. 2000 Mar-Apr;55(2):277-82.

引用本文的文献

1
Evaluation of Vancomycin Area Under the Concentration-Time Curve Predictive Performance Using Bayesian Modeling Software With and Without Peak Concentration: An Academic Hospital Experience for Adult Patients Without Renal Impairment.使用具有和不具有峰浓度的贝叶斯建模软件评估万古霉素浓度-时间曲线下面积的预测性能:来自无肾功能损害成年患者的学术医院经验。
Ann Lab Med. 2023 Nov 1;43(6):554-564. doi: 10.3343/alm.2023.43.6.554. Epub 2023 Jun 30.
2
Pharmacokinetic Modeling of Hydrocortisone by Including Protein Binding to Corticosteroid-Binding Globulin.通过纳入与皮质类固醇结合球蛋白的蛋白质结合来进行氢化可的松的药代动力学建模。
Pharmaceutics. 2022 May 30;14(6):1161. doi: 10.3390/pharmaceutics14061161.
3
Evaluation of the Robustness of Therapeutic Drug Monitoring Coupled with Bayesian Forecasting of Busulfan with Regard to Inaccurate Documentation.
评估治疗药物监测与贝叶斯预测相结合对不准确记录的苯丁酸氮芥的稳健性。
Pharm Res. 2021 Oct;38(10):1721-1729. doi: 10.1007/s11095-021-03115-8. Epub 2021 Oct 18.
4
Impact of Inaccurate Documentation of Sampling and Infusion Time in Model-Informed Precision Dosing.模型引导精准给药中采样和输注时间记录不准确的影响
Front Pharmacol. 2020 Mar 3;11:172. doi: 10.3389/fphar.2020.00172. eCollection 2020.
5
Vancomycin Pharmacokinetics Throughout Life: Results from a Pooled Population Analysis and Evaluation of Current Dosing Recommendations.万古霉素药代动力学:一项汇总人群分析结果及对当前剂量推荐的评估。
Clin Pharmacokinet. 2019 Jun;58(6):767-780. doi: 10.1007/s40262-018-0727-5.
6
Darunavir Population Pharmacokinetic Model Based on HIV Outpatient Data.基于HIV门诊数据的达芦那韦群体药代动力学模型。
Ther Drug Monit. 2019 Feb;41(1):59-65. doi: 10.1097/FTD.0000000000000576.
7
Food intake and darunavir plasma concentrations in people living with HIV in an outpatient setting.门诊环境中 HIV 感染者的食物摄入与达芦那韦血浆浓度。
Br J Clin Pharmacol. 2017 Oct;83(10):2325-2329. doi: 10.1111/bcp.13366. Epub 2017 Aug 1.